Join        Login             Stock Quote

Quest Diagnostics (DGX) To Sell Hemocue Business, Announces Hurricane Sandy Impact

 January 16, 2013 07:29 AM

(By Mani) Quest Diagnostics Inc. (NYSE: DGX) said it plans to sell its HemoCue diagnostic products business to refocus on diagnostic information services, and its fourth quarter earnings were reduced by 6 cents a share due to Hurricane Sandy.

The sale of HemoCue business, which develops point-of-care testing systems, follows the divestiture of OralDNA products business, which was sold in December 2012. The company would take asset impairment charges of $89.5 million, or 56 cents a share, in the fourth quarter results related to these two sales.

As a result, the company's consolidated income statements for the full-year 2012 and 2011 will present the operating results of HemoCue and OralDNA as discontinued operations.

Separately, the company said, due to Hurricane Sandy, its fourth quarter revenues were reduced by an estimated $21 million, and operating income by an estimated $16 million.

Quest Diagnostics is expected to report its fourth-quarter results on Jan.23. Wall Street expects the company to earn $1.08 a share on revenue of $1.83 billion, according to analysts polled by Thomson Reuters.

iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageEmerging-Markets Stocks Took The Lead Last Week

Emerging-markets equities enjoyed a solid rise last week among the major asset classes, based on a set of read on...

article imageDoes Your Latest Investment Pass This Test?

On Wednesday, I sounded the alarm about the problems looming for some consumer staples stocks. In short, read on...

article imageIs The Slump In US Manufacturing Easing?

Yesterday’s November survey data from the Philadelphia Fed hints at the possibility that a stronger trend read on...

article imageMarket Potentially Facing Near Term Technical Headwinds

After the S&P 500 Index pullback on Thursday and Friday last week, the market's advance on Monday and read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.